228
Participants
Start Date
September 1, 2023
Primary Completion Date
September 30, 2025
Study Completion Date
September 30, 2027
gemcitabine,nimotuzumab, toripalimab
same as before
gemcitabine, cisplatin
same as before
RECRUITING
Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an
Air Force Military Medical University, China
OTHER